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~1-c pcptidc-t (7-36)asn&(GLP-( (7-36)amidt) reprewnts a physiologically important incrctin in mammals including man. Receptors 
for GLP-I (7-3@amide ba\r &n drskii in RWttSF cclk We hawz solubilized active GLP-I(736]ami& rcccptors from RINmSF cell 
mcmbraocrutilidngtbtdcr~~~~~ucosilcand~APSrTriton X-loOand Lubtol PXwttuineikctivc_BindittgoTradiofab~lcdGLP-1(7- 
_~-a to the wd -or was inhibited cmtccttttationdcPcndcntly b addition of unlab&d pcptide. Scatchard analysis of binding data 
rcwakd a siugk class of binding sites u-itb I&= (25 r. cr.03 nM and &,,= 65.4 4 II.24 fmob’mg ofptotcin for the mcmbmnobound rcccptor and 
A$= W 2 ~.QJJM and B,_= 3.9 5 TtS9 pmoYmg of protein for the solubilii mccptor. The binding ofthc radiolabel to the solubilizcd mccptor 
uasdcpmdcntholhontlrcconcen uatiotts of mane and dhalcttt cations and the protcin/detcrgcnt ratio in the incubation buffkr. The membrane 
bound maptor is satsiti\c to guanine-nwkotitk howwcr neither GTP-y-S nor GDP-&S affcctcd binding of lab&xl peptide to solubilized 
raeptor. These data in&ate tha1 ihe somilii nmptor may haw lost association with its G-protein. In conclusion. the hem p-ted ~IVIOCO~ 
allour. sdu!Sition of the GLP-l(f-Warni& receptor in a fun&ma1 state. and opens up the possibility for further molecular characterization 
of the receptor protein. 
GLP-1(7-36)attidc Rcoqtor: Solubikation: RiNmSF 
1. lNTRODUCTiON 
It is ~11 established that postprandially rclcased in- 
testinal homoues positively modulate insulin secretory 
function [ 11. Rcccnt findings suegest glucagon-like pep- 
tide (GLP-1(7-36)amidc) rcprcscnts an important phys- 
iological incretin in mammals including man i2l. 
GLP- I (7-3S)amide is a post-translational product of 
prcproglucagon processing In the mammalian intestine 
13.41. It is rclcascd into the c+t.&tion in rcsponsc to 
oral glucose [q and has a potem stimulating &ect on 
the glusosc-induced insulin secretion [4.6-Q Furthcr- 
more. it was demonstrated that GLP-1(7-36)amidc 
strongly inhibits the pentagastrin-induced gastric acid 
output [9.10]. Thus. GLP-l(?-36)amidc is. in addition 
to a proposed role as an incretin also under considcra- 
tion as an ‘emerogastrone’ candidate 
Pruviously, WC idcntificd and characterized GLP-1(7- 
36jamide receptors on rat insulinoma-dcrivcd RlNmSF 
cells 1111 and rat lung plasma membranes [I 2) WC dcm- 
onstntcd that. after binding to RlNmSF a%. GLP- 
1(7-~34kamide is intcrnalii and further proass;cd 
intncctiularl~ 1131. Furtl-wmoa, binding of GLP-1(7, 
W-amide ta RlNmSF c&s rsults in a qclic AMP in- 
crcasc [l 11. Morcovcr. binding ofGLP-1(7-36)amidc to 
RlNmSF and rat lung plasma membranes is decreased 
in the prcscncc of guanine nuctcotidcs [ 14.151 indicating 
that GLP-1(7-36)amide receptors in RlNmSF cells and 
rat lung are coupled to G-proteins. 
In the present study WC present a protocol allowing 
the so’ruZlization of GLP- 1(7-36)amidc receptors in an 
active form. This is of particular intcrcst since up to now 
the solubilized receptor for GLP-1(7-36)amidc has not 
hccn available to allow further detailed biochcmicai 
chardcterizaLion. 
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2.3. Prepurution q/’ RlNmSF plasma membranes 
RlNmSF plasma mcmbrancs were prepared as described previously 
117. Briefly, approximately 6 x IO” celts were resuspended in im)d 
buffer CTris-HCl 10 mM; NaCl30 mM. dithiothkitd 1 mM,‘PMSF 
5 PM.’ pH 7.5) and disrupted using a glass-glass homogenizer. The 
homogenate was layered aver a 41% (w/v) sucrose solution a d cen- 
trifuged at 95.000 x g for 60 min at 4°C. The band or membranes at 
the interface OS’ the layers was collected, diluted fourfold with homog- 
enisation buffer and centrifuged for 30 min at 40.000 x g and 4’C. The 
pellets were resuspended in salubilization buff‘er (HEPES 10 mM, 
PMSF 1 mM, NaCl118 mM. WI 4.7 mM, MgCI, 5 mM. EGTA 1 
mM, pH 7.4) frozen in liquid nitrogen and stored at -80°C. Protein 
concentrations were measured as described by Bradford [IS]. 
2.4. Solubilixhon of the GLP-i/7-36)amide receptor 
RlNmSF plasma mcmbrancs were thawed and diluted with solu- 
bilization but&r containing different detergents (octyl-&ghtcoside. 
CHAPS, Lubrol PX, T&on X-100: final concentration 1%). Only the 
solubilizcd proteins with octyl-j3-glucosidc and CHAPS retained sufti- 
cirnt quantities of GLP-I (7-36)amidc binding activity. For subse- 
qucnt studies octyl-&glucosidc was used since it gave the highest 
yields. For solubihaation of GLP-1(7-36)amidc receptors RlNmSF 
plasma membranes (1 mgml) were incubated in solubilization buffer 
containing octyl-fi-glucosidc (final concentration I%. w/v) for I h at 
4°C in a gently rotating plastic centrifugation tube. After centriruga- 
tion for 60 min at 100.000 x g at 4°C the suprnatant was frozen in 
liquid nitrogen and stored at -80°C until USC. 
2.5. Receptor binding studies 
Binding studies with [‘z’l]GLP-1(7-36)amidc vvcrc carried out for 
60 min at 20°C in a total volume of 250plltube. The incubation buffer. 
unless othemise indicated, conttitcd ;,~rtiS 10 mM, M&i, 5 mM. 
NaCl118 mM, KCI 4.7 mM. EGTA 1 mM, PMSF 40pM. bacitracin 
0.01% (w/v) and human sccum albuminO.Ol% (w/v). pH 7.4. Tl** final 
concentration of octyl-&tlucosidc was 0.2%. Binding assay was tcr- 
minatcrl by addition of human y-globulin (final conccnttation 0.25 
m&ml) and polycthylcne glycol (PEG: final concentration 10%) fol- 
lowed by a centrifugation for 30 min at 2,000 x g at 4OC. Pcllcts vvcrc 
count-d in a y-counter. 
Bolh radioactivity associtncd to the PEG pcllct in the abscncc of 
solubilizcd rcccptors (blanks), and non-spccitic binding, dclincd its 
0.25 
1 
Fig. I. Eniri al’dill’crcnt detcrgcnts on the solubilization of]“‘l]GLP- 
1(? 36)amidc binding &vi@. RINmSF plasma mcmbtllncs (1 my 
protein/ml) wcrc incuhntcvl for 60 min itI 4°C with ocryl-&g)ucosidc 
II% W’v) 1 I). Trilon X-)tW (I% w/v1 (2). CHAPS (I% w/v) (3) or 
Lubro) PX (I% w/v) (4). After cxmlrifugation for 66 min ill IotI.WI) 
.c L: nl 4°C nliquotv of’thc *upzmatant wcrc incub;ttcll with (“‘t]GLI*,+ 
l(7~036)amidr (oppror. 40.00 cpm) for 60 min dt 20°C. Uatn *how 
mcanr f S.E.M. of 10 expcr;mcntr. 
binding in the prcscnce of an excess of uniabcllcd GLP-l(7-36)amide 
(1 PM). wcrc substracted in each cxpcriment. 
3. RESULTS 
3.1 Soiubilization ofGLP-1 f 7-36)amide receptors 
Four detergents (octyl-B-glucoside, Triton X-100, 
CHAPS and Lubrol PX) were investigated for their 
ability to solubilize active GLP-1(7-36)amide binding 
protein from RINmSF plasma membranes. The highest 
yields of GLP-1(7-36)amide binding activity were ob- 
tamed with octyl-fl-glucoside and CHAPS (Fig. 1). For 
the further experiments octyl-&glucoside was used. 
Sohtbilization of GLP-1(7-36)amide binding activity 
was optimal at an octylj3glucoside concentration of 
1% (Fig. 2a). The use of a higher detergent concentra- 
tion resulted in a decrease ofthe obtained binding activ- 
ity. The optimal protein-detergent ratio was 1:15 (Fig. 
2b). 
Binding of (“51~GLF-l~7-36)amide to solubiliied re- 
ceptors was dependent on the amount of solubiliied 
protein used (Fig. 3a). 
3.2. Effect of cations on the binding o~,F[“~I]GLP-~ (7- 
36)anlide to solubilized receptors 
In previous studies investigating the binding of 
[“51]GLP-t(7-36)amide to RINmSF cells and RINmSF 
plasma membraxs we used a modified Krebs-Ringer- 
HEPES buffer [ 111. To optimize the conditions we now 
studied the effect of monovalent and divalent cations on 
the binding of tracer to solubilized receptors. Using a 
IO mM HEPES-buffer <pH 7.4) containing 1 mM 
EGTA. human serum albumin 0.01% (w/v). bacitracin 
0.01% (w/v) and 1 mM PMSF without cations no spe- 
cific binding of tracer to solubilized receptors was de- 
tectable. Addition of MgCI, (5 mM) caused asignificant 
increase of tracer binding which was stronger than that 
observed after the addition of CaCl, (5 mM) (Fig. 3b). 
The presence of monovaknt cations was necessary for 
optimal bipling of [‘?‘l]GLP-I(?-36)::~id~ x :;o:I.~ .:!- 
izcd receptors. The optimal butler had the following 
composition: HEPES 10 mM. MgC& 5 mM, NaCl 118 
mM. KCI 4.7 mM, EGTA I mM. PMSF 1 mM, baci- 
tracin 0.01% (w/v) and human swum albumin 0.01% 
(w/v) pH 7.4. 
3.3. Ejkct u/’ grrariine nrrclcotides on bkding of 
[‘2s”IjGL P-l ( 7-36)anride to solubilk~~d rcccplors 
To study the efkxt of guaninc nuclcotidcs on tracer 
binding. solubilizcd receptor proteins wcrc incubated 
with [iz~llGLP-l(7-36)umidc in the nbscncc and pre% 
cncc 01’ the non-ilydrotyzablc ittKt!ogS GTP-7-S (9.1 
mM) ilnd GDP-/I-S (0, I mM). Both guaninc nuclcotidc 
unulogs h;td IIU cfkx :a\ \hc BinJittg of [‘“IjGLP-I(7~~- 
J6)amide to so]Bbi]ircd GLIB- 1(7- 36);unidc rcwzplors 
<‘Fig. 4). 
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Fig, 2. la) Efkt of octyl#3-glucosidc concentration on the solubilira- 
tion of [1~IjGLP-l(7-36)amidc binding activity. RINmSF plasma 
mcrn& ( 1 mg protein/ml) wm incubated with the indiitcd octyl- 
8-glucoride conantrations for60 min at 4% Ahcr cpntrifugation for 
60 mjn al iOO.OW x g at 4°C apiquots of the supcrnatant wcxc in- 
cubated with I’~IIGLP-l(7-36)amie(Ppprox. 4O.Wkpm) for 60 min 
at -WC. Data poims show means f: S.E.M. of 10 expcrimcnts. (b) 
Binding of[*~fJGLP-1(7-36)amide as a function of octyl-j-glucosidc- 
to-pro&n ratio. S&b&cd rwptors uvc iacubatfd with f’JIFLP- 
1(7-36)amide (approx. 40&W cpm) in rhc presence of an incrtkng 
amount of oetyd&gUoskWmg protein for 60 min at 20°C. Data 
pointi Jhow means of tripliit+z of a simple r pmscntativc of three 
C%perimenlS. 
Fig. 3. Effect of prowin concentration on binding of [‘-“llGLP-lU- 
3h)amidc. AClcr solubikation of RINmSF plasma mctnbrancs (I mg 
protcitiml) increasing protein coficcntrations were incubated with 
[‘“CELP-1(7-36)amide (approx. 4O.OOo cpm) for 60 I;: .J al 4°C Data 
pohtts how means + S.E.M. 01’4 cxperimcnts. (b) Efkct of mono- and 
divalcnt cations on [‘“JI~LP-1(7-36)amidc binding to solubilizcd rc- 
ccptors. Solubilizcd rcccptor$ wcrc incubated with [“‘IIGLP-I(:, 
36)amide (approx. 40,000 cpm) in HEPES (10 mM) buff& (pH 7.4) 
containing PMSF (1 mM) in the ptescncc of (1) EGTA ( 1 mM + 
MgC& (5 mM). (2) CacI, (5 mMi. (3j EGTA (1 mM) + NaC) (I IS 
mM) + KC) (4.7 mM). (4) EGTA (I mM) + M&I: (5 mM) + NaCl 
(II% mM) + KC1 (4.7 mM). or (5) Cat& (5 mM) + NaCl (II8 mM1 
+ KC3 (4.7 mM). for 60 min at WC. Data show means 2 S.E.M. of 
S cxpcrimmts. 
4.42 FM and 3.9 + 0.?9 pmaYmg of protein for solubil- 
ized receptors. respectively. 
Ita precious stud&. WC idcntificd and chawztcrizcd 
re~xptors I’or GLP-1(7V~36famidc on RlNmSF cell? 
[91.17]. ROlmSF cells possess a sin& class of GLT- 
Ii7-,36)amidc binding sites which arc coupled to the 
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Fig. 4. Effect of guanine nuclcotidcs on [“~IIGLP-1(7-.36)amidc bind- 
ing. Solubiliied receptors were incubated with [‘LsI]GLP-I(7-36)amide 
(approx. 40.000 cpm) in the abscncc (1) and preettce of GTP-y-S (0.1 
mM) (2) or GDP+S (0.1 mM) (3) for 60 min at 20°C. Data show 
means zk S.E.M. of 16 cxpcriments. 
adenylate cyclase system [ 11,14,17]. Investigations 
using reducing agents howed f’ : the binding Frotein 
of the receptor is not attached to other subunits via 
disulphide bonds [17]. In additional studies, tq.dio- 
labelled GLP-1(7-36)amide was cross-linked to GLP- 
1(7-36)amide receptors in RINmSF plasma 
membranes. Further analysis by SDS-PAGE and auto- 
radiography revealed that the molecular mass of the 
ligand-binding protein complex is 63,000 [ 171. 
The present study was carried out to solubilize active 
GLP-1(7-36)amide receptors from RINmSF 
membranes thereby employing various detergents. De- 
tergents arc widely used to solubilize proteins from cel- 
lular membranes. Receptors have been solubilized using 
Triton insulin (201, IGF-II (211 and EGF [22]; Lubrol 
was used to solubilize benzodiazepin receptor [23], 
CHAPS for solubilization of opiate [24] and prolactin 
[25] receptors. and octyl+glucosidc for solubilization 
of VIP receptor [26]. We investigated Triton X-100, 
Lubrol PX, CHAPS and octyl-&glucoside for their abil- 
ity to solubilize active GLP-1(7-36)amidc receptors 
from RINmSF plasma membranes. Solubilization with 
octyl+glucoside and CHAPS gave highest yields of 
active GLP-1(7-36)amidc receptors. There was no sig- 
nificant difference of the ability of these both detergents 
in solubilizing active GLP-1(7-.36)amidc receptors. 
For further cxpcrimcnts octyl-j?-glucosidc was used. 
The optimal final concentration ofthc dctergcnt was 1% 
(w/v) and the optima! protcin&tclgcnt ratio wiis I : 15. 
Binding of (‘““l]GLP-I(7-,36)amidc was proportional lo 
the amount of solubilizcd protein. investigating the role 
of mono- and divatcnt cations WC found that the prcs- 
cnce of Na*. K’ and Mg?’ in the incubation bufl’cr was 
important for maximal specific ligand binding. Similar 
results have been found in studies with solubilired CCK 
receptors from mouse pan-s [27j. 
Receptors for GLP-1(7-36)amide a~ r+~pled to the 
adenylatc yclase system [141. Therefore it is easy to 
understand that bindirig of [t251]GLP-1(7-36)amide to 
RINmSF plasma membranes is decreaxd when 
guanine nucleotides are added to the test system [14]. 
However, binding of [‘“I]GLP-I(7-36)amide to solubil- 
ized receptors was not affected by guanine nucleotides 
which indicates that the GLP-l-receptor protein may be 
solubilized as a single protein without a G-protein 
attached. Another finding argues in the same direction: 
tracer binding to RINmSF plasma membranes i in- 
hibited by GLP-1(7-36)amide in a concentrationde- 
pendent manner with a & of 0.26 nM. The same is true 
for binding of radiolabelled GLP-1(7-36)amide to sol- 
ubilized receptors but the Kd is 22.54 PM which indi- 
cated a significantly reduced affinity of the receptor 
against he ligand. Support for these results comes from 
previous observations that a,-adrenergic. /?-adrenergic, 
CCK and D,-dopaminergic receptors lose their sensi- 
tivity to guanine nucleotides and their high-affinity 
binding after solubilization [28-321. Another interesting 
feature of solubilized GLP-1-rcccptors is that they ex- 
hibited a much higher binding capacity than membrane- 
bound receptors. This could be due to an exposition of 
cryptic GLP-1(7-36)amide-specific binding sites as has 
been suggested similarly for CCK receptors [27]. On the 
other haod. solubilization and separation from other 
membrane proteins could mean a relative nrichment of 
specific binding sites. 
Our resuhs show that active GLP-1(7-36)amide r - 
ceptors can bc solubilizcd from RlNmSF membranes. 
This opens up the possibility to further purify these 
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